Annual EBITDA
-$4.69 M
+$11.47 M+70.97%
31 December 2023
Summary:
Rockwell Medical annual earnings before interest, taxes, depreciation & amortization is currently -$4.69 million, with the most recent change of +$11.47 million (+70.97%) on 31 December 2023. During the last 3 years, it has risen by +$22.03 million (+82.43%). RMTI annual EBITDA is now -551.82% below its all-time high of $1.04 million, reached on 31 December 2004.RMTI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$2.51 M
+$1.39 M+123.22%
30 September 2024
Summary:
Rockwell Medical quarterly earnings before interest, taxes, depreciation & amortization is currently $2.51 million, with the most recent change of +$1.39 million (+123.22%) on 30 September 2024. Over the past year, it has increased by +$3.41 million (+379.71%). RMTI quarterly EBITDA is now at all-time high.RMTI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$3.02 M
+$3.41 M+891.62%
30 September 2024
Summary:
Rockwell Medical TTM earnings before interest, taxes, depreciation & amortization is currently $3.02 million, with the most recent change of +$3.41 million (+891.62%) on 30 September 2024. Over the past year, it has increased by +$9.64 million (+145.69%). RMTI TTM EBITDA is now at all-time high.RMTI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMTI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +71.0% | +379.7% | +145.7% |
| 3 y3 years | +82.4% | +139.4% | +111.0% |
| 5 y5 years | +84.7% | +134.9% | +108.9% |
RMTI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +83.1% | at high | +132.7% | at high | +110.9% |
| 5 y | 5 years | at high | +85.1% | at high | +132.7% | at high | +108.9% |
| alltime | all time | -551.8% | +91.1% | at high | +114.3% | at high | +105.2% |
Rockwell Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.51 M(+123.2%) | $3.02 M(-891.6%) |
| June 2024 | - | $1.12 M(-248.9%) | -$382.00 K(-91.0%) |
| Mar 2024 | - | -$755.00 K(-617.1%) | -$4.25 M(-9.5%) |
| Dec 2023 | -$4.69 M(-71.0%) | $146.00 K(-116.3%) | -$4.69 M(-29.1%) |
| Sept 2023 | - | -$897.00 K(-67.3%) | -$6.62 M(-28.7%) |
| June 2023 | - | -$2.74 M(+127.8%) | -$9.29 M(-14.7%) |
| Mar 2023 | - | -$1.20 M(-32.4%) | -$10.89 M(-32.7%) |
| Dec 2022 | -$16.17 M(-41.8%) | -$1.78 M(-50.1%) | -$16.17 M(-26.8%) |
| Sept 2022 | - | -$3.56 M(-17.9%) | -$22.07 M(-11.3%) |
| June 2022 | - | -$4.34 M(-33.1%) | -$24.88 M(-10.3%) |
| Mar 2022 | - | -$6.48 M(-15.6%) | -$27.73 M(-0.3%) |
| Dec 2021 | -$27.80 M(+4.0%) | -$7.68 M(+20.7%) | -$27.80 M(+0.7%) |
| Sept 2021 | - | -$6.37 M(-11.4%) | -$27.60 M(+0.8%) |
| June 2021 | - | -$7.19 M(+9.6%) | -$27.37 M(+5.3%) |
| Mar 2021 | - | -$6.56 M(-12.4%) | -$26.00 M(-2.7%) |
| Dec 2020 | -$26.72 M(-15.0%) | -$7.49 M(+22.0%) | -$26.72 M(+3.2%) |
| Sept 2020 | - | -$6.14 M(+5.5%) | -$25.89 M(-3.9%) |
| June 2020 | - | -$5.82 M(-20.1%) | -$26.93 M(-12.3%) |
| Mar 2020 | - | -$7.28 M(+9.5%) | -$30.72 M(-2.3%) |
| Dec 2019 | -$31.45 M(+2.2%) | -$6.65 M(-7.4%) | -$31.45 M(-7.6%) |
| Sept 2019 | - | -$7.18 M(-25.2%) | -$34.04 M(+7.5%) |
| June 2019 | - | -$9.60 M(+19.8%) | -$31.67 M(-4.6%) |
| Mar 2019 | - | -$8.01 M(-13.3%) | -$33.18 M(+7.9%) |
| Dec 2018 | -$30.76 M(+21.1%) | -$9.24 M(+92.0%) | -$30.76 M(+0.5%) |
| Sept 2018 | - | -$4.81 M(-56.7%) | -$30.61 M(-0.3%) |
| June 2018 | - | -$11.11 M(+98.8%) | -$30.70 M(+17.3%) |
| Mar 2018 | - | -$5.59 M(-38.5%) | -$26.17 M(+3.0%) |
| Dec 2017 | -$25.41 M(+36.3%) | -$9.09 M(+85.6%) | -$25.41 M(+23.4%) |
| Sept 2017 | - | -$4.90 M(-25.6%) | -$20.59 M(+1.7%) |
| June 2017 | - | -$6.59 M(+36.5%) | -$20.25 M(+6.3%) |
| Mar 2017 | - | -$4.83 M(+13.0%) | -$19.06 M(+2.3%) |
| Dec 2016 | -$18.64 M(+37.0%) | -$4.27 M(-6.4%) | -$18.64 M(-4.6%) |
| Sept 2016 | - | -$4.56 M(-15.3%) | -$19.53 M(+12.7%) |
| June 2016 | - | -$5.39 M(+22.4%) | -$17.34 M(+20.4%) |
| Mar 2016 | - | -$4.41 M(-14.7%) | -$14.40 M(+6.8%) |
| Dec 2015 | -$13.60 M(-15.9%) | -$5.17 M(+117.9%) | -$13.48 M(+4.4%) |
| Sept 2015 | - | -$2.37 M(-3.4%) | -$12.92 M(-3.3%) |
| June 2015 | - | -$2.45 M(-29.7%) | -$13.37 M(+3.0%) |
| Mar 2015 | - | -$3.49 M(-24.2%) | -$12.97 M(-19.8%) |
| Dec 2014 | -$16.18 M(-64.8%) | -$4.60 M(+63.6%) | -$16.18 M(-13.8%) |
| Sept 2014 | - | -$2.81 M(+36.4%) | -$18.78 M(-33.1%) |
| June 2014 | - | -$2.06 M(-69.2%) | -$28.06 M(-25.2%) |
| Mar 2014 | - | -$6.69 M(-7.1%) | -$37.52 M(-18.4%) |
| Dec 2013 | -$45.95 M(-13.2%) | -$7.20 M(-40.5%) | -$45.95 M(-11.9%) |
| Sept 2013 | - | -$12.10 M(+5.0%) | -$52.16 M(-9.5%) |
| June 2013 | - | -$11.52 M(-23.9%) | -$57.67 M(-0.2%) |
| Mar 2013 | - | -$15.13 M(+12.8%) | -$57.77 M(+9.1%) |
| Dec 2012 | -$52.93 M(+161.2%) | -$13.41 M(-23.8%) | -$52.93 M(+9.8%) |
| Sept 2012 | - | -$17.60 M(+51.4%) | -$48.22 M(+36.3%) |
| June 2012 | - | -$11.63 M(+13.0%) | -$35.38 M(+26.5%) |
| Mar 2012 | - | -$10.29 M(+18.2%) | -$27.97 M(+38.0%) |
| Dec 2011 | -$20.26 M | -$8.70 M(+82.8%) | -$20.26 M(+57.3%) |
| Sept 2011 | - | -$4.76 M(+12.9%) | -$12.88 M(+51.2%) |
| June 2011 | - | -$4.22 M(+63.3%) | -$8.52 M(+121.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$2.58 M(+95.5%) | -$3.84 M(+199.0%) |
| Dec 2010 | -$1.28 M(-69.7%) | -$1.32 M(+228.0%) | -$1.28 M(+1051.1%) |
| Sept 2010 | - | -$402.60 K(-186.7%) | -$111.60 K(-87.8%) |
| June 2010 | - | $464.30 K(-1892.7%) | -$917.70 K(-67.1%) |
| Mar 2010 | - | -$25.90 K(-82.4%) | -$2.79 M(-34.2%) |
| Dec 2009 | -$4.24 M(-40.9%) | -$147.40 K(-87.8%) | -$4.24 M(-38.6%) |
| Sept 2009 | - | -$1.21 M(-14.1%) | -$6.91 M(-13.3%) |
| June 2009 | - | -$1.41 M(-4.8%) | -$7.97 M(+6.3%) |
| Mar 2009 | - | -$1.48 M(-47.4%) | -$7.50 M(+4.5%) |
| Dec 2008 | -$7.17 M(+169.8%) | -$2.81 M(+23.8%) | -$7.17 M(+38.8%) |
| Sept 2008 | - | -$2.27 M(+142.9%) | -$5.17 M(+68.4%) |
| June 2008 | - | -$935.10 K(-19.1%) | -$3.07 M(+29.1%) |
| Mar 2008 | - | -$1.16 M(+43.4%) | -$2.38 M(-10.6%) |
| Dec 2007 | -$2.66 M(-31.5%) | -$805.80 K(+366.3%) | -$2.66 M(-5.9%) |
| Sept 2007 | - | -$172.80 K(-29.1%) | -$2.82 M(-31.1%) |
| June 2007 | - | -$243.70 K(-83.0%) | -$4.10 M(-22.0%) |
| Mar 2007 | - | -$1.44 M(+48.0%) | -$5.25 M(+35.3%) |
| Dec 2006 | -$3.88 M(-554.6%) | -$971.10 K(-32.8%) | -$3.88 M(+33.0%) |
| Sept 2006 | - | -$1.45 M(+3.5%) | -$2.92 M(+167.6%) |
| June 2006 | - | -$1.40 M(+1929.1%) | -$1.09 M(-282.9%) |
| Mar 2006 | - | -$68.80 K(+829.7%) | $596.00 K(-30.2%) |
| Dec 2005 | $853.70 K(-17.8%) | -$7400.00(-101.9%) | $853.70 K(-22.4%) |
| Sept 2005 | - | $382.10 K(+31.7%) | $1.10 M(+10.4%) |
| June 2005 | - | $290.10 K(+53.6%) | $996.30 K(+4.0%) |
| Mar 2005 | - | $188.90 K(-20.8%) | $957.90 K(-7.8%) |
| Dec 2004 | $1.04 M(+61.9%) | $238.40 K(-14.5%) | $1.04 M(-4.0%) |
| Sept 2004 | - | $278.90 K(+10.8%) | $1.08 M(+4.5%) |
| June 2004 | - | $251.70 K(-6.7%) | $1.04 M(+21.2%) |
| Mar 2004 | - | $269.90 K(-4.1%) | $854.20 K(+33.1%) |
| Dec 2003 | $641.80 K(-236.5%) | $281.50 K(+21.3%) | $641.90 K(+56.7%) |
| Sept 2003 | - | $232.00 K(+227.7%) | $409.70 K(+192.9%) |
| June 2003 | - | $70.80 K(+22.9%) | $139.90 K(-175.7%) |
| Mar 2003 | - | $57.60 K(+16.8%) | -$184.80 K(-60.7%) |
| Dec 2002 | -$470.30 K(-55.5%) | $49.30 K(-230.4%) | -$470.30 K(-40.9%) |
| Sept 2002 | - | -$37.80 K(-85.1%) | -$795.90 K(-27.3%) |
| June 2002 | - | -$253.90 K(+11.4%) | -$1.09 M(+0.3%) |
| Mar 2002 | - | -$227.90 K(-17.5%) | -$1.09 M(+12.7%) |
| Dec 2001 | -$1.06 M(+58.6%) | -$276.30 K(-18.0%) | -$968.80 K(+32.6%) |
| Sept 2001 | - | -$336.90 K(+34.3%) | -$730.40 K(+21.0%) |
| June 2001 | - | -$250.90 K(+139.6%) | -$603.40 K(-2.3%) |
| Mar 2001 | - | -$104.70 K(+176.3%) | -$617.60 K(-7.2%) |
| Dec 2000 | -$665.60 K(-4.9%) | -$37.90 K(-81.9%) | -$665.70 K(+6.0%) |
| Sept 2000 | - | -$209.90 K(-20.8%) | -$627.80 K(+1.6%) |
| June 2000 | - | -$265.10 K(+73.5%) | -$617.90 K(-5.3%) |
| Mar 2000 | - | -$152.80 K(<-9900.0%) | -$652.80 K(-8.8%) |
| Dec 1999 | -$700.00 K(-50.0%) | $0.00(-100.0%) | -$715.80 K(0.0%) |
| Sept 1999 | - | -$200.00 K(-33.3%) | -$715.80 K(-21.8%) |
| June 1999 | - | -$300.00 K(+39.0%) | -$915.80 K(0.0%) |
| Mar 1999 | - | -$215.80 K(<-9900.0%) | -$915.80 K(-16.7%) |
| Dec 1998 | -$1.40 M(-12.5%) | $0.00(-100.0%) | -$1.10 M(-21.4%) |
| Sept 1998 | - | -$400.00 K(+33.3%) | -$1.40 M(+40.0%) |
| June 1998 | - | -$300.00 K(-25.0%) | -$1.00 M(+42.9%) |
| Mar 1998 | - | -$400.00 K(+33.3%) | -$700.00 K(+133.3%) |
| Dec 1997 | -$1.60 M | -$300.00 K | -$300.00 K |
FAQ
- What is Rockwell Medical annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Rockwell Medical?
- What is Rockwell Medical annual EBITDA year-on-year change?
- What is Rockwell Medical quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Rockwell Medical?
- What is Rockwell Medical quarterly EBITDA year-on-year change?
- What is Rockwell Medical TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Rockwell Medical?
- What is Rockwell Medical TTM EBITDA year-on-year change?
What is Rockwell Medical annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RMTI is -$4.69 M
What is the all time high annual EBITDA for Rockwell Medical?
Rockwell Medical all-time high annual earnings before interest, taxes, depreciation & amortization is $1.04 M
What is Rockwell Medical annual EBITDA year-on-year change?
Over the past year, RMTI annual earnings before interest, taxes, depreciation & amortization has changed by +$11.47 M (+70.97%)
What is Rockwell Medical quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RMTI is $2.51 M
What is the all time high quarterly EBITDA for Rockwell Medical?
Rockwell Medical all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.51 M
What is Rockwell Medical quarterly EBITDA year-on-year change?
Over the past year, RMTI quarterly earnings before interest, taxes, depreciation & amortization has changed by +$3.41 M (+379.71%)
What is Rockwell Medical TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RMTI is $3.02 M
What is the all time high TTM EBITDA for Rockwell Medical?
Rockwell Medical all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.02 M
What is Rockwell Medical TTM EBITDA year-on-year change?
Over the past year, RMTI TTM earnings before interest, taxes, depreciation & amortization has changed by +$9.64 M (+145.69%)